Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is W  [Clear All Filters]
Gertz MA. Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management. Am J Hematol. 2013.
Mummery C, Fischer Y, Gathier A. Welcome to stem cell reports. Stem Cell Reports. 2013;1(1):1-2.
Tischler AS. What happens in "chromospheres"?. Stem Cells Transl Med. 2013;2(12):1020.
Chan SSun-Kin, Kyba M. What is a Master Regulator?. J Stem Cell Res Ther. 2013;3.
Zaydfudim VM, Smoot RL, Nagorney DM. What is the Role of Bone Marrow-Derived Stem Cells in Hepatic Hypertrophy After Portal Vein Embolization?. Ann Surg. 2013.
Karsten U, Goletz S. What makes cancer stem cell markers different?. Springerplus. 2013;2(1):301.
da Costa CT, de Almeida MR, Ruedell CM, Schwambach J, Maraschin FS, Fett-Neto AG. When stress and development go hand in hand: main hormonal controls of adventitious rooting in cuttings. Front Plant Sci. 2013;4:133.
Lee Y-K, Cowan CA. White to brite adipocyte transition and back again. Nat Cell Biol. 2013;15(6):568-569.
Odintsov B, Chun JLan, Berry SE. Whole Body MRI and Fluorescent Microscopy for Detection of Stem Cells Labeled with Superparamagnetic Iron Oxide (SPIO) Nanoparticles and DiI Following Intramuscular and Systemic Delivery. Methods Mol Biol. 2013;1052:1-17.
Yamanaka S. The Winding Road to Pluripotency (Nobel Lecture). Angew Chem Int Ed Engl. 2013.
Heo SChul, Kwon YWoo, Jang IHo, Jeong GOk, Yoon JWon, Kim CDae, Kwon SMo, Bae Y-S, Kim JHo. WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony forming cells. Stem Cells. 2013.
Xin H-W, Ambe CM, Ray S, Kim B-K, Koizumi T, Wiegand GW, Hari D, Mullinax JE, Jaiswal KR, Garfield SH, et al. Wnt and the cancer niche: paracrine interactions with gastrointestinal cancer cells undergoing asymmetric cell division. J Cancer. 2013;4(6):447-57.
Varela-Nallar L, Inestrosa NC. Wnt signaling in the regulation of adult hippocampal neurogenesis. Front Cell Neurosci. 2013;7:100.
Jiang W, Zhang D, Bursac N, Zhang Y. WNT3 Is a Biomarker Capable of Predicting the Definitive Endoderm Differentiation Potential of hESCs. Stem Cell Reports. 2013;1(1):46-52.
Gertow K, Hirst CE, Yu QC, Ng ES, Pereira LA, Davis RP, Stanley EG, Elefanty AG. WNT3A Promotes Hematopoietic or Mesenchymal Differentiation from hESCs Depending on the Time of Exposure. Stem Cell Reports. 2013;1(1):53-65.
Leucht P, Jiang J, Cheng D, Liu B, Dhamdhere G, Fang MYang, Monica SD, Urena JJ, Cole W, Smith LR, et al. Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals. J Bone Joint Surg Am. 2013;95(14):1278-88.
Cook DA, Fellgett SW, Pownall ME, O'Shea PJ, Genever PG. Wnt-dependent osteogenic commitment of bone marrow stromal cells using a novel GSK3β inhibitor. Stem Cell Res. 2013;12(2):415-427.
Cai W-Y, Wei T-Z, Luo Q-C, Wu Q-W, Liu Q-F, Yang M, Ye G-D, Wu J-F, Chen Y-Y, Bin Sun G-, et al. Wnt/β-catenin pathway represses let-7 microRNAs expression via transactivation of Lin28 to augment breast cancer stem cell expansion. J Cell Sci. 2013.
Gu Z, Tan W, Feng G, Meng Y, Shen B, Liu H, Cheng C. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway. Mol Cell Biochem. 2013.
Zhang B, Krawetz R, Rancourt DE. Would the real human embryonic stem cell please stand up?. Bioessays. 2013.
Gish LA, Gagne JM, Han L, Deyoung BJ, Clark SE. WUSCHEL-Responsive At5g65480 Interacts with CLAVATA Components In Vitro and in Transient Expression. PLoS One. 2013;8(6):e66345.